These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 4597182)

  • 21. Detection of H-Y (male) antigen on mouse lymph node cells by the cell to cell cytotoxicity test.
    Goldberg EH; Shen FW; Tokuda S
    Transplantation; 1973 Mar; 15(3):334-6. PubMed ID: 4576043
    [No Abstract]   [Full Text] [Related]  

  • 22. Induction of immunity to a mouse lymphoma by multiple methods, including vaccination with soluble membrane fractions.
    Prager MD; Hollinshead AC; Ribble RJ; Derr I
    J Natl Cancer Inst; 1973 Nov; 51(5):1603-7. PubMed ID: 4587139
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro modification of donor bone marrow used to produce enhanced graft survival in antilymphocyte serum (ALS)-treated mice.
    Gozzo JJ; Wood ML; Pompei R; Monaco AP
    Transplant Proc; 1973 Mar; 5(1):853-6. PubMed ID: 4572148
    [No Abstract]   [Full Text] [Related]  

  • 24. [Role of discrete cell populations in the effect of stimulation of antibody formation in a mixed culture of immune lymph node and intact bone marrow cells].
    Petrov RV; Stepanenko RN; Mikhaĭlova AA
    Dokl Akad Nauk SSSR; 1975; 220(1):230-2. PubMed ID: 1167494
    [No Abstract]   [Full Text] [Related]  

  • 25. Attempts to raise heterologous antisera against subcellular antigenic extracts.
    Haenen-Severyns AM; Degiovanni G; Lejeune GN; Castermans A
    Eur Surg Res; 1970; 2(1):64-72. PubMed ID: 4131421
    [No Abstract]   [Full Text] [Related]  

  • 26. Cell-mediated immunity and blocking serum activity before and after breakage of allograft tolerance in rats.
    Bansal SC; Hellström I; Hellström KE; Wright PW
    Transplantation; 1973 Dec; 16(6):610-20. PubMed ID: 4585385
    [No Abstract]   [Full Text] [Related]  

  • 27. Modulation of the H-2 antigenicity on the surface of murine peritoneal cells.
    Schlesinger M; Chaouat M
    Tissue Antigens; 1972; 2(6):427-35. PubMed ID: 4648385
    [No Abstract]   [Full Text] [Related]  

  • 28. Antilymphocytic antibodies and marrow transplantation. IV. Comparison of the effects of antibody fragments directed against immunoglobulin or lymphocyte antigens on acute secondary disease.
    Rodt H; Therfelder S; Eulitz M
    Exp Hematol; 1974; 2(4):195-203. PubMed ID: 4156327
    [No Abstract]   [Full Text] [Related]  

  • 29. Prolonged survival of tumor allografts in mice pretreated with soluble transplantation antigens.
    Rosenberg EB; Hill J; Ferarri A; Herberman RB; Ting CC; Mann DL; Fahey J
    J Natl Cancer Inst; 1973 Jun; 50(6):1453-8. PubMed ID: 4717562
    [No Abstract]   [Full Text] [Related]  

  • 30. Local graft-versus-host reaction suppressed by immuno-blocking antibody secreted by antibody-forming cells transferred with the graft.
    Fink MP; Cloud CL; McCarthy KF
    Cell Immunol; 1974 Mar; 11(1-3):74-85. PubMed ID: 4156195
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunological enhancement, blocking factors, and tolerance to tumours, transplants and foetuses.
    Halliday WJ
    Aust N Z J Med; 1972 Nov; 2(4):416-21. PubMed ID: 4572903
    [No Abstract]   [Full Text] [Related]  

  • 32. Humoral factors in specific unresponsiveness to transplantation antigens.
    Brent L; Kilshaw PJ
    Transplant Proc; 1976 Jun; 8(2):209-15. PubMed ID: 779181
    [No Abstract]   [Full Text] [Related]  

  • 33. Regional lymph node response in rats to injection of semi-allogeneic lymphocytes. Time, weight, dose, and histocompatibility relations.
    Meyer H; Heron I
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1973 Dec; 81(6):724-30. PubMed ID: 4150121
    [No Abstract]   [Full Text] [Related]  

  • 34. Allograft tolerance: presumptive evidence that serum factors from tolerant animals that block lymphocyte-mediated immunity in vitro are soluble antigen-antibody complexes.
    Wright PW; Hargreaves RE; Bansal SC; Bernstein ID; Hellström KE
    Proc Natl Acad Sci U S A; 1973 Sep; 70(9):2539-43. PubMed ID: 4582187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Passive enhancement of mouse skin allografts. Specificity of the antiserum for major histocompatibility.
    Staines NA; Guy K; Davies DA
    Transplantation; 1974 Aug; 18(2):192-5. PubMed ID: 4602953
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies on the induction and expression of T cell-mediated immunity. I. Blocking of cell-mediated cytolysis by membrane antigens.
    Bonavida B
    J Immunol; 1974 Mar; 112(3):926-34. PubMed ID: 4544178
    [No Abstract]   [Full Text] [Related]  

  • 37. Blocking of syngeneic effector T cells by soluble tumour antigens.
    Plata F; Levy JP
    Nature; 1974 May; 249(454):271-4. PubMed ID: 4545403
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cooperative interaction of cells in the immune response].
    Chertkov IL; Fridenshteĭn AIa
    Usp Sovrem Biol; 1972; 74(2):292-307. PubMed ID: 4118261
    [No Abstract]   [Full Text] [Related]  

  • 39. Workshop summary on genetic determinants of cell-mediated immune reactions in the mouse.
    Festenstein H; Démant P
    Transplant Proc; 1973 Dec; 5(4):1321-7. PubMed ID: 4149543
    [No Abstract]   [Full Text] [Related]  

  • 40. Soluble mouse histocompatibility antigens.
    Koene R; McKenzie IF; Painter E; Sachs DH; Winn HJ; Russell PS
    Transplant Proc; 1971 Mar; 3(1):231-3. PubMed ID: 4106314
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.